Lui Shiong Lee

Associate Professor Lee Lui Shiong is currently Head of Department, Department of Urology, Sengkang General Hospital, and a visiting senior consultant with National Cancer Centre Singapore. With a keen in interest in urologic-oncology, he spear-headed the development of a robotic cystectomy and intra-corporeal reconstruction service, alongside an Enhanced Recovery After Surgery programme and oversaw the development of a one-stop multi-disciplinary clinic with NCCS , catered to patients with advanced urological cancers with the intention of providing holistic care supported by evidence based practices. Beyond the MDT clinic, he maintains a strong interest in multi-visceral resection surgery such as pelvic exenterations and inferior venae-cavae thrombectomy. He also has strong collaborations with the GAP3 Global Consortium in Prostate Cancer Active Surveillance and the Asian Robotic Cystectomy Consortium. He has also held several research grants supporting investigator initiated trials and studies focused on urologic oncology. He has also led several award winning QI projects involving improving patient safety and clinical outcomes. For his efforts in pursuing better clinical outcomes through innovation, he was awarded the Singapore Health Quality Service Award 2024 in the Clinician Exemplar Leader category. As Site Director for the Singhealth Urology Residency Programme in Sengkang General Hospital, he oversees residency training and development and was recognised as an Outstanding Faculty Member in 2022. He is the current President of the Singapore Urological Association.

14th August 2025

Time Session

15th August 2025

Time Session
15:30
17:00
Oncology 2
Prostate Cancer
  • Prostate Cancer
    Kai-Jie YuTaiwan Moderator
    Lui Shiong LeeSingapore Moderator
  • Focal Therapy in Asia – Is It Prime Time?
    Peter Ka-Fung ChiuHong Kong, China Speaker
  • Primary Radical Prostatectomy in Low Volume Metastatic Prostate Cancer
    Zainal Adwin Zainal AbiddinMalaysia Speaker
  • Transperineal Microwave Ablation Therapy (TMA) for Localized Prostate Cancer
    Khairul Asri Mohd GhaniMalaysia Speaker
  • The Strategy to Initiate PSMA-Based Therapies for Advanced Prostate Cancer
    Chung-Hsin ChenTaiwan Speaker
  • Discussion
TICC - 2F 201BC

17th August 2025

Time Session
08:30
10:00
Plenary Session 6
  • TBD
    Chun-Te WuTaiwan Moderator
  • SIU Lecture: Role of MISTs in Male LUTS Surgical Management (Will TUR-P/ Laser Prostatectomy be Replaced?)
    Rohan MalekMalaysia Moderator
    Jeremy TeohHong Kong, China Speaker
  • Updates on Molecular Classification and Diagnostics of Upper Urinary Tract Urothelial Carcinoma
    Haruki KumeJapan Speaker
  • A Fully Automated Artificial Intelligence System to Assist Pathologists' Diagnosis to Predict Histologically High-Grade Urothelial Carcinoma from Digitized Urine Cytology
    John Jang Hwan KimKorea (Republic of) Moderator
    Osamu UkimuraJapan Speaker
  • Recommendations in Laser Use for the Treatment of Upper Tract Urothelial Carcinoma
    Bou SopheapCambodia Moderator
    Athanasios PapatsorisGreece Speaker
  • UTUC Treatment — Evidence & Guideline Recommendation
    Lui Shiong LeeSingapore Moderator
    Yuki EndoJapan Speaker
TICC - 3F Banquet Hall